Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Antiviral Research|December 27, 2011
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4Nicolas A Margot, Rebecca M Hluhanich, Gregg S Jones, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integraseGregg S Jones, Fang Yu, Ameneh Zeynalzadegan, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2008
Tricyclic HIV integrase inhibitors: potent and orally bioavailable C5-aza analogsHaolun Jin, Matthew Wright, Richard Pastor, et al.
Biochemistry|January 13, 2011
Dithiothreitol causes HIV-1 integrase dimer dissociation while agents interacting with the integrase dimer interface promote dimer formationManuel Tsiang, Gregg S Jones, Magdeleine Hung, et al.
The Journal of Biological Chemistry|October 6, 2009
Affinities between the binding partners of the HIV-1 integrase dimer-lens epithelium-derived growth factor (IN dimer-LEDGF) complexManuel Tsiang, Gregg S Jones, Magdeleine Hung, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2021
Long Dissociation of Bictegravir from HIV-1 Integrase-DNA ComplexesKirsten L White, Nathan Osman, Ernesto Cuadra-Foy, et al.
The Journal of Biological Chemistry|April 27, 2012
New class of HIV-1 integrase (IN) inhibitors with a dual mode of actionManuel Tsiang, Gregg S Jones, Anita Niedziela-Majka, et al.
Journal of Natural Products|February 6, 2014
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cellsEric J Mejia, Steven T Loveridge, George Stepan, et al.
Organic Letters|January 7, 2015
Abyssomicin 2 reactivates latent HIV-1 by a PKC- and HDAC-independent mechanismBrian León, Gabriel Navarro, Bailey J Dickey, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2016
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance ProfileManuel Tsiang, Gregg S Jones, Joshua Goldsmith, et al.
Pageof 2